A similar study in 328 colorectal adenocarcinomas treated with surgery demonstrated the overexpression of CD47 in 16% of patients, which was associated with node involvement, tumor budding and poor recurrence-free survival [95]. This evidence concerns the gene CD47 and neoplasm.